Flucytosine (5FC) for mycoses

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Jul 2024: Trial registered, NCT06525389

The trials

NCT06525389: Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

State
Not started
Phase
Phase 3
People
428 planned
Started
Nov 2026
Primary completion
1 Sep 2030
Arms
Deoxycholate Amphotericin B (DAmB) plus Flucytosine (5FC)
Results
None posted
  1. 29 Jul 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.